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Abstract
Because the superficial lymphatics in the lungs are distributed in the subpleural, interlobular and peribroncovascular interstitium, 
lymphatic impairment may occur in the lungs of patients with idiopathic interstitial pneumonias (IIPs) and increase their severity. 
We investigated the distribution of lymphatics in different remodeling stages of IIPs by immunohistochemistry using the D2-40 
antibody. Pulmonary tissue was obtained from 69 patients with acute interstitial pneumonia/diffuse alveolar damage (AIP/DAD, 
N = 24), cryptogenic organizing pneumonia/organizing pneumonia (COP/OP, N = 6), nonspecific interstitial pneumonia (NSIP/
NSIP, N = 20), and idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP, N = 19). D2-40+ lymphatic in the lesions 
was quantitatively determined and associated with remodeling stage score. We observed an increase in the D2-40+ percent from 
DAD (6.66 ± 1.11) to UIP (23.45 ± 5.24, P = 0.008) with the advanced process of remodeling stage of the lesions. Kaplan-Meier 
survival curves showed a better survival for patients with higher lymphatic D2-40+ expression than 9.3%. Lymphatic impairment 
occurs in the lungs of IIPs and its severity increases according to remodeling stage. The results suggest that disruption of the 
superficial lymphatics may impair alveolar clearance, delay organ repair and cause severe disease progress mainly in patients 
with AIP/DAD. Therefore, lymphatic distribution may serve as a surrogate marker for the identification of patients at greatest 
risk for death due to IIPs.
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Pulmonary fluid homeostasis is modulated by the bal-
ance between fluid filtration into the pulmonary interstitium 
from blood capillaries and its removal from the interstitium 
via the lymphatic system (1-5). Impairment of pulmonary 
lymphatic flow due to several pathological situations such 
as pulmonary edema results in excess fluid accumulation 
within the pulmonary interstitium, which often leads to inter-
stitial fibrosis, pleural effusion and subsequent pulmonary 
dysfunction (1,2). In the mammalian lung, lymph is drained 
from the subpleural lymphatic plexus to the periaxial lym-
phatic plexus through interlobular lymphatic channels (6). 
These pulmonary lymphatic networks have been repeatedly 
investigated in detail in humans and animals by observa-
tions using dye-injection techniques, electron microscopy 
and lymphangiography (5). However, these techniques 
are inappropriate for histopathological observation of the 
lymphatic system in formalin-fixed paraffin-embedded tis-
sues obtained from lung tissues.
In idiopathic interstitial pneumonias (IIPs), parenchymal 
remodeling after alveolar damage results in scar formation 
through several sequential stages of epithelial cell necrosis, 
alveolar collapse, apposition of alveolar septa, and fibrosis 
(7). In the process of pulmonary remodeling, the viable epi-
thelial cells around the lesion express cytoprotective proteins 
and cytokines, which facilitate the remodeling of the affected 
lesion (8). Pulmonary remodeling is, thus, dependent on 
various contributors, and vascular factors are critical for 
angiogenesis in the healing area (9,10). Vascular factors 
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are promptly expressed in the surviving alveolar epithelium 
around the infarcted lesion after injury (11,12). The process 
of angiogenesis and lymphagiogenesis in the remodeling 
process of IIPs has been investigated sporadically (9-14). 
This is probably due to the lack of a reliable marker that 
can distinguish the lymphatic endothelium from the blood 
capillary endothelium. In recent years, lymphatic endothelial 
cell-specific proteins have been identified, including VEGF 
receptor-3, lymphatic endothelial hyaluronan receptor-1 
(LYVE-1), podoplanin, prox-1, D6 and D2-40 (15,16). In 
the lung, recent studies have reported lymphatic morphol-
ogy and density in diffuse alveolar damage (DAD) and 
organizing pneumonia (OP) by immunohistochemistry but 
did not include nonspecific interstitial pneumonia (NSIP) 
or usual interstitial pneumonia (UIP) (13,14). Because the 
superficial lymphatics in the lungs are distributed in the 
subpleural, interlobular and peribroncovascular interstitium, 
we hypothesized that lymphatic impairment would occur in 
the lungs of IIPs and increase their severity. In the present 
study, we investigated lymphatic distribution in the entire 
process of parenchymal remodeling in DAD, OP, NSIP, and 
UIP by immunohistochemistry using the D2-40 antibody, 
which is considered to be the most sensitive and specific 
marker for lymph vessel endothelium (16). Furthermore, 
the impact of these findings was evaluated as a function of 
physiological testing and survival of the patients.
Patients and Methods
Patient selection
Pulmonary tissue was obtained from 69 surgical lung 
biopsies from patients with IIPs. The biopsies were classi-
fied according to the American Thoracic Society/European 
Respiratory Society (ATS/ERS) consensus classification 
(17). A remodeling stage score was attributed to each 
group and included: 
Diffuse alveolar damage. DAD was characterized by 
involvement and a uniform temporal appearance caused 
by alveolar collapse, hyaline membrane, septal inflamma-
tion, and obliterative organizing fibrosis (17) (score 1), N = 
24 cases (Figure 1A).
Organizing pneumonia. OP was characterized by a focal 
injury in the epithelial cell-epithelium basement membrane 
unit resulting in the formation of granulation tissue in the 
airspace consisting of single stalk, plump myofibroblasts 
embedded in an edematous stroma with mononucleated 
inflammatory cells, capillary vessels and moderate organiz-
ing fibrosis (17) (score 2), N = 6 cases (Figure 1C).
Nonspecific interstitial pneumonia cellular pattern. 
NSIP was characterized by temporally homogenous septal 
inflammatory thickening and minimal organizing fibrosis 
(17) (score 3), N = 20 cases (Figure 1E).
Usual interstitial pneumonia. UIP was defined by al-
ternating areas of normal parenchyma, alveolar collapse, 
honeycombing, and severe mural organizing fibrosis, de-
fined as sites of active remodeling overlying fibrous airspace 
walls, and thus showing temporal heterogeneity, or overlying 
normal rigid pulmonary structures (e.g., interlobular septa) 
in the form of fibroblast foci and granulation tissue (17) 
(score 4), N = 19 cases (Figure 1G).
All patients included exhibited clinical, radiological 
and physiological changes consistent with acute intersti-
tial pneumonia (AIP), cryptogenic organizing pneumonia 
(COP), NSIP, or idiopathic pulmonary fibrosis (IPF). Two 
or three biopsy specimens per patient were sampled and 
the tissue were collected according to the high-resolution 
computed tomography pattern, which usually includes 
normal, intermediate and more affected areas in different 
parts of the lung. Thus, the diagnosis of our patients with 
IIPs was obtained by clinical, radiological and histological 
consensus criteria.
For semi-quantitative analysis, UIP histological pattern 
was divided into three different stages (10): alveolar col-
lapse, mural organizing fibrosis and honeycomb. The UIP 
alveolar collapse stage was characterized by focal mural 
fibrosis, minimal inflammatory activity and sparse honey-
combing transformation. In the UIP mural fibrosis stage, the 
pulmonary parenchyma showed a high degree of inflam-
matory activity, focal mural fibrosis and moderate paren-
chymal honeycombing changes. Pulmonary parenchyma 
showing extensive areas of mural fibrosis, fibroblastic foci 
and honeycomb remodeling corresponded to the third UIP 
stage (honeycombing). These three stages were evaluated 
by two experienced pathologists in the area.
Baseline characteristics
The median age of the patients was 47 years (range 
19-74) for AIP (13 men, 10 women), 54 years (range 40-60) 
for COP (4 men, 2 women), 50.8 years (range 39-76) for 
NSIP (11 men, 9 women), and 66 years (range 48-76) for 
IPF (12 men, 7 women).
Physiological testing
The pulmonary function tests included forced expiratory 
volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/
FVC ratio 6100, total lung capacity (TLC), residual volume 
and carbon monoxide transfer factor (DLCO). TLC, residual 
volume and residual volume/TLC percentages were mea-
sured by the helium-dilution method with a Master Screen 
Apparatus (Erich Jaeger GmbH, Germany), and DLCO and 
DLCO/alveolar volume by the single breath-holding helium-
dilution method (18). Lung function measurements are 
reported as percentages of predicted values. In all patients, 
arterial PaO2 and PaCO2 were also measured at rest. The 
cardiac parameters of these patients were normal.
Tissue preparation and immunohistochemistry
All pulmonary tissue was fixed in 10% neutral buffered 
formalin and embedded in paraffin. Thin sections were 
stained with hematoxylin and eosin. Additional subserial 
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sections from all the paraffin blocks were used for immuno-
histochemistry. The antibody used was D2-40 (Signet Labora-
tory Inc., USA). Immunohistochemistry was performed using 
the Envision (+) kit (Dako Cytomation, USA) according to 
manufacturer instructions. Sections were visualized by treat-
ing the slides with diamino-benzidine-tetrahydrochloride. To 
demonstrate antibody specificity, sections from each paraffin 
block were used as negative controls by omitting the primary 
antibody and replacing it with normal mouse or rabbit immuno-
globulin. Positive expression of D2-40 was indicated by brown 
cytoplasmic staining.
Morphometry 
The sections immunostained with D2-40 antibody were 
observed by light microscopy at 400X magnification. Only 
vessels with a lumen or consisting of more than a single 
endothelial cell positive for D2-40 were considered to be 
lymphatic vessels. We used an eyepiece grid with 100 
points and 50 lines to quantify the area and the lymphat-
ics immunostained for D2-40+ as follows: Ten fields were 
chosen from across multiple sites accounting/adjusting 
for cellularity or as number of positively stained cells per 
mesenchymal tissue (19). In other words, the parenchymal 
area in each field was determined according to the number 
of points hitting on positive cells, as a proportion of the total 
grid area. Afterward, the number of positive cells within 
the parenchymal area was counted. The immunostaining 
cellularity was determined as the number of positive cells 
in each field divided by the parenchymal area. The final 
results are reported as means ± standard deviation (SD) 
of the lung specimens of each patient in 10 random, non-
coincident microscopic fields.
To control for variation in scoring between our two his-
tologists (ERP and VLC), 20% of the stained slides were 
independently scored by both observers. The coefficient 
of variance between cell counts for the two observers was 
<5%.
Statistical analysis
Data are reported as means ± SD. Statistical analysis 
was performed by analysis of variance followed by appropri-
ate post hoc tests including the Student t-test for variables. 
Survival curves were determined by the Kaplan-Meier 
method and the risk of death was estimated by Cox regres-
sion. The statistical program used was SPSS, Inc. (USA). A 
P value less than 0.05 was considered to be significant. 
Results
Distribution of lymphatic vessels according to 
pulmonary parenchymal remodeling stage score
In DAD, a few D2-40+ lymphatic vessels were identified 
in the region of thickened alveolar septa or in the peripheral 
interstitium of the affected area (Figure 1A and B).
In OP, we observed few D2-40 lymphatic vessels around 
the bronchovascular interstitium and in granulation tissue of 
the intraluminal plugs. The lymphatic vessels were tortuous 
and with minimal dilatation (Figure 1C and D).
In the NSIP pattern, we detected a few D2-40+ lymphatic 
vessels in the region of thickened alveolar septa. Lymphatic 
vessels were observed with more dilatation than in OP 
(Figure 1E and F).
In the UIP histological pattern, lymphatic vessels 
presented a large luminal area and were observed in the 
peripheral region and around fibroblastic foci (Figure 1G 
and H). Lymphatic vessels were increased in the interlobular 
and subpleural space.
Lymphatic distribution was significantly related to paren-
chymal remodeling score in DAD, OP, NSIP, and UIP. In other 
words, the organizing fibrosis present as obliterative (score 
1) in DAD, the intraluminal plugs (score 2) observed in OP, 
the septal inflammatory thickening and minimal organizing 
fibrosis (score 3) of NSIP, and the mural organizing fibrosis 
and fibroblast foci (score 4) found in UIP were significantly 
related to the density of lymphatic vessels (Figure 2).
Fluctuation of lymphatic vessels according to 
pulmonary parenchymal remodeling stage score
Lymphatic D2-40+ in the four categorized lesions is 
indicated in Figure 2. Lymphatic D2-40+ differed significantly 
in the lesions of the four categories. D2-40 expression 
increased with the progression from DAD (6.66 ± 1.11), 
OP (15.35 ± 3.75), NSIP (15.49 ± 1.80), up to UIP (23.45 
± 5.24).
Pulmonary function tests and survival 
Thirty-five patients died during the 180-month follow-
up period (20 AIP, 1 COP, 5 NSIP, and 9 IPF). All patients 
studied had a restrictive lung function pattern characterized 
by a decrease in TLC (mean values were 57% of predicted 
values for AIP, 55% for NSIP and 75% for IPF) and an 
increase in FVC/FEV1 ratio (mean values were 97% of 
predicted values for AIP, 88% for COP, 109% for NSIP, and 
118% for IPF). The mean predicted values of DLCO were 
decreased in patients with NSIP (51%) and IPF (53%). 
The pulmonary function of patients with AIP, COP, NSIP, 
and IPF and with different degrees of organizing fibrosis 
and lymphatic density did not differ significantly between 
groups. We analyzed the survival curves by comparing 
patient characteristics (baseline data and physiological 
test) and distribution and fluctuation of lymphatic vessels 
according to pulmonary parenchymal remodeling stage. 
Kaplan-Meier survival curves showed that patients with a 
9.3% median lymphatic vessel density in lung parenchyma 
presented higher survival than patients with a <9.3% median 
lymphatic vessel density in lung parenchyma (125 vs 45 
months, respectively). Multivariate analyses by the Cox 
regression model showed statistical significance (log likeli-
hood = 61.98; P = 0.000) for low risk of death for patients 
<55 years (OR = 0.17) with OP (OR = 0.01) and with high 
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FVC (OR = 0.9), whereas a high risk of death was found for 
male patients (OR = 6.73) and with lymphatic density <9.3% 
(OR = 11.03). Regression plots of survival probability versus 
follow-up time in months in patients with IIPs showed that 
the group with lymphatic density >9.3% had better survival 
than the group with <9.3% (Figure 3). 
Discussion
The present study using morphometry revealed a 
large increase of the lymphatics in the interlobular and 
subpleural space, in which massive fibrosis increased with 
the development of new lymphatics in the lungs of patients 
with UIP. In contrast, in the lungs of patients with DAD, OP 
and cellular NSIP, a few lymphatics had extended into the 
alveolar lesions from the superficial lymphatics, especially 
into granulation tissues within the alveolar space. Although 
massive fibrotic diseases developed in IPF, including fi-
broblastic foci, lymphatic vessel density was increased in 
the lungs of UIP, probably draining excessive proteins and 
Figure 1. Histology of the diffuse al-
veolar damage (A,B), organizing pneu-
monia (C,D), nonspecific interstitial 
pneumonia (E,F), and usual intersti-
tial pneumonia (G,H). Diffuse alveo-
lar damage characterized by hyaline 
membranes (HM), alveolar collapse 
(AC), septal inflammation, and oblit-
erative organizing fibrosis (A); note a 
few D2-40+ lymphatic vessels in the 
thickened alveolar region (arrows; B). 
Organizing pneumonia (C) showing 
prominent areas of myxoid organiz-
ing pneumonia (MOP) characterized 
by proliferation of plump fibroblasts 
embedded in an edematous stroma, 
forming intraluminal plugs in alveolar 
ducts and alveoli; anti-D2-40 immuno-
histochemical (D) stain decorates lym-
phatic lumens in organizing pneumo-
nia; note peribronchial and intra-plug 
(MOP) (arrows) distribution of D2-40+. 
Nonspecific interstitial pneumonia (E) 
showing homogenous thickening of the 
alveolar septa by inflammatory cell pro-
liferation (asterisks); anti-D240 immu-
nohistochemical stain decorates lym-
phatic lumens in nonspecific interstitial 
pneumonia (arrows; F) in the peribron-
chovascular region, while the lumens 
are absent along the alveolar septa 
of the affected area. Usual interstitial 
pneumonia (G) showing alternating ar-
eas of normal parenchyma (asterisks), 
honeycombing (triangles) and organiz-
ing fibrosis with fibroblastic foci (FF), in 
detail; anti-D2-40 immunohistochemi-
cal stains lymphatics (arrows; H) with 
a large area or dilated in the peripheral 
region of honeycombing changes; note 
fibroblastic foci (FF) overlying the sur-
face of the airspace or enlarged and re-
modeled airspaces with dense scars in 
the walls (asterisks). Hematoxylin and 
eosin (A-D). Peroxidase (E-H).
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fluid. These results suggest that the increase of 
superficial lymphatics may improve alveolar clear-
ance, accelerate organ repair and avoid disease 
progress in patients with IPF. 
Lymphatic dilatation was not detected in the 
early stages of the remodeling process, but a few 
dilated lymphatics first appeared in the peripheral 
region adjacent to viable epithelial cells in the 
early process of fibroblastic foci. Lymphatic dila-
tation subsequently increased during the mural 
fibrosis period and was maintained thereafter 
during scar formation. In addition, LDE increased 
in the early stage of intraluminal granulation of 
OP and septal inflammatory thickening of NSIP, 
abruptly decreased in stages with DAD, but with 
a subsequent increase with the process of mural 
fibrosis in UIP. From these results, it can be seen 
that, during the entire process of parenchymal 
remodeling, the lymphatics mainly participate in 
fibrosis maturation and scar formation through the 
drainage of excessive proteins and fluid.
In the lung tissue of IIPs investigated in the 
present study, D2-40+ lymphatics were abundant 
in the subpleural regions, as well as in the interlobu-
lar interstitium. These findings are consistent with 
the distribution patterns of pulmonary lymphatics 
confirmed by other methods (5). In the light of 
lymphatic distribution, the abundant lymphatics 
in the subpleural region detected by D2-40 im-
munohistochemistry seem to correspond to the 
subpleural lymphatic plexus (6). Previous stud-
ies describing lymphatic distribution in sections 
of normal renal tissue (16,20) and other reports 
have also demonstrated the usefulness of D2-40 
immunohistochemistry for detecting lymphatic 
capillaries in the renal interstitium (21). 
Parenchymal remodeling after pulmonary in-
jury is characterized by an increase in pulmonary 
endothelial and epithelial permeability. This early 
phase is followed by a subacute fibroproliferative 
phase that may allow repair of the injured lung 
or result in progressive obliteration of the inter-
stitial and alveolar compartments of the lung by 
a fibroproliferative process that may be in fact 
established by 24 h after the injury (22). In this 
process of epithelial necrosis, extracellular matri-
ces are degraded by inflammatory cell proteases 
(23-25). Based on such early events after the onset 
of parenchymal remodeling, it is supposed that 
pre-existing vascular tissues in the affected area 
also disintegrate through the influence of ischemia 
and inflammatory cells. The present results have 
clearly demonstrated that D2-40+ lymphatic ves-
sels were poorly detected in the affected areas 
of early remodeling such as DAD, OP and NSIP 
Figure 2. Lymphatic density according to score for the four lesions. Lym-
phatic D2-40+ in 10 fields of view observed by light microscopy at 400X 
magnification. The values of lymphatic D2-40+ are 6.66 ± 1.11 in diffuse al-
veolar damage (DAD), 15.35 ± 3.75 in organizing pneumonia (OP), 15.49 ± 
1.80 in nonspecific interstitial pneumonia (NSIP), and 23.45 ± 5.24 in usual 
interstitial pneumonia (UIP). Lymphatic density increases from DAD score 
1, OP score 2, NSIP score 3, up to UIP score 4 with a statistically significant 
difference. *P < 0.01 (ANOVA).
Figure 3. Multivariate analysis by Cox regression plots of survival prob-
ability versus follow-up time in months in patients with idiopathic interstitial 
pneumonia (IIP). The group with lymphatic density higher than 9.3% ap-
pears as the top curve, and the group with lymphatic density lower than 
9.3% appears as the bottom curve (log likelihood = 61.98; P < 0.001).
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compared to the UIP late stage. Lymphatics in the periph-
eral pulmonary interstitium consist of single-layered, thin 
endothelial cells, which possess an undeveloped basement 
membrane with no pericytes around them (6). These char-
acteristics of lymphatic structures may cause vulnerability 
to ischemic damage and/or degradation by proteases, as 
is the case for blood capillaries. 
In the present study, LDE surprisingly increased in the 
late mural fibrosis stage of UIP, when newly formed blood 
capillaries were usually decreased, as previously described 
by Parra et al. (10). In general, lymphangiogenesis devel-
ops through budding, sprouting and/or remodeling from 
pre-existing vessels, which frequently occur in pathological 
conditions, such as malignant tumors (26,27). In the process 
of cutaneous wound healing in the mouse model, lymphatics 
appear in subcutaneous tissue along the wound edge at 3-5 
days after injury (28). It is therefore hypothesized that newly 
formed lymphatics first appear in the peripheral area of the 
lesion through sprouting from the pre-existing lymphatics 
around the lesion, and the proliferation of lymphatics follows 
after blood vessel angiogenesis.
In the current study, LDE significantly increased with 
healing maturation from the NSIP stage up to the UIP stage. 
These results indicate that lymphatics mainly participate in 
the maturation of fibrosis and/or scar formation through the 
drainage of excessive proteins and fluid. Based on these 
descriptions, including our results, it is considered that the 
role of lymphatics during parenchymal remodeling may be 
maintained for a longer time than that of blood vessels and 
that immunohistochemistry using a lymphatic endothelial 
marker is useful in investigating the role of lymphatics in 
IIPs.
Our study has clinical implications. In order to establish 
the relevance of these findings to patient evolution, lymphatic 
distribution in AIP/DAD, COP/OP, NSIP/NSIP, and IPF/UIP 
was evaluated in terms of physiological testing and survival. 
Clearly, multivariate analyses showed a low risk of death 
for female patients with OP and high FVC, but a high risk 
for males with median age >55 years and low lymphatic 
D2-40+ expression.
Finally, lymphatic distribution may serve as a surrogate 
marker for the identification of patients at greatest risk for 
death in IIPS. 
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